SERUM THYROID MICROSOMAL ANTIBODIES (MCHA) AND THEIR PREDICTIVE VALUE OF OVERT THYROID DISEASE IN DIADETIC CHILDREN: A LONGITUDINAL STUDY

F. Luca,F. Irinarchi,T. Arrigo,S. Bernasconi

DOI: https://doi.org/10.1203/00006450-198801000-00202

IF: 3.953

Pediatric Research

Abstract:Whilst the last 10 years'literature unanimously points out the increased prevalence of serum MCMA in children and youngsters with insulin-dependent diabetes mellitus (IODM), the predictive value of overt thyroid disease of such a biohumoral marker in these patients widely varies according to the different Authors:frcquently >40% in US reports, generally < 10% in European reports. We followed for a 5-yr period 12 MCHA positive IDDM children (12/99 vs a prevalence of 6/197 found in an age-matched control group, X2=9.5, p<0.005), who underwent semestral clinical and biochemical (T4, T3, FT4, FT3, TSH, TSH response to i.v. TRH) assessments of thyroid function. Results: a) during the whole follow-up period, the MCHA titers have been fluctuating up and down in all patients, with no effects on thyroid function tests; b) no patient has been showing goiter or other clinical signs of thyroid dysfunction; c) no patient has been exhibiting persistent or even transient changes in thyroid function tests suggestive of hypothyroidism or hyperthyroidism; d) in 4/12 cases the first TRH-test elicited a TSH hyperresponse suggestive of subclinical hypothyroidism, but such a pattern was not confirmed at the next tests.Conclusions: based on a longitudinal study, our data confirm that the increased prevalence of MCHA in IDDM children is not associated to high risk of overt thyroid disease, at least in Europe.